KERYX BIOPHARMACEUTICALS INC

CUSIP: 492515101 Class: COMMON STOCK

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q1 2018
Shares 302,157 Value ($000) $1,236 Avg Close — Range —
Q4 2017
Shares 302,157 Value ($000) $1,405 Avg Close — Range —
Q3 2017
Shares 400,000 Value ($000) $2,840 Avg Close — Range —
Q2 2017
Shares 425,111 Value ($000) $3,074 Avg Close — Range —
Q1 2017
Shares 425,111 Value ($000) $2,619 Avg Close — Range —
Q4 2016
Shares 425,111 Value ($000) $2,491 Avg Close — Range —
Q3 2016
Shares 500,111 Value ($000) $2,655,589 Avg Close — Range —
Q2 2016
Shares 450,111 Value ($000) $2,980 Avg Close — Range —
Q1 2016
Shares 950,000 Value ($000) $4,437 Avg Close — Range —
Q4 2015
Shares 1,233,000 Value ($000) $6,227 Avg Close — Range —
Q3 2015
Shares 1,563,000 Value ($000) $5,502 Avg Close — Range —
Q2 2015
Shares 534,000 Value ($000) $5,329 Avg Close — Range —
Q1 2015
Shares 297,000 Value ($000) $3,781 Avg Close — Range —
Q4 2014
Shares 90,424 Value ($000) $1,279 Avg Close — Range —
Q3 2014
Shares 136,000 Value ($000) $1,870 Avg Close — Range —
Q2 2014
Shares 240,000 Value ($000) $3,691 Avg Close — Range —
Q1 2014
Shares 265,325 Value ($000) $4,521 Avg Close — Range —
Q4 2013
Shares 400,000 Value ($000) $5,180 Avg Close — Range —